Correlation of baseline characteristics and health care utilization in the multicenter cohort of children with SCD who underwent PSG
| . | All (N = 210) . | ED visits, r (P value) . | Hospital admissions, r (P value) . | All encounters, r (P value) . |
|---|---|---|---|---|
| Age, mean (SEM), y | 9.7 (0.3) | 0.28 (<.0001) | 0.38 (<.0001) | 0.35 (<.0001) |
| Sex, males (%) | 102 (49) | 0.03 (.66) | 0.04 (.49) | 0.04 (.57) |
| Genotype | ||||
| SS + Sβ0 vs SC + Sβ+, n (%) | 169 (80) vs 41 (20) | 0.14 (<.05) | 0.18 (<.05) | 0.17 (<.05) |
| Hb, mean (SEM) | 8.7 (0.1) | –0.15 (<.05) | –0.22 (<.01) | –0.20 (<.01) |
| MCV, mean (SEM) | 86.1 (1.0) | 0.08 (.29) | 0.13 (.11) | 0.11 (.17) |
| Hydroxyurea use (%) | 132 (63) | 0.10 (.07) | 0.13 (<.01) | 0.17 (<.05) |
| . | All (N = 210) . | ED visits, r (P value) . | Hospital admissions, r (P value) . | All encounters, r (P value) . |
|---|---|---|---|---|
| Age, mean (SEM), y | 9.7 (0.3) | 0.28 (<.0001) | 0.38 (<.0001) | 0.35 (<.0001) |
| Sex, males (%) | 102 (49) | 0.03 (.66) | 0.04 (.49) | 0.04 (.57) |
| Genotype | ||||
| SS + Sβ0 vs SC + Sβ+, n (%) | 169 (80) vs 41 (20) | 0.14 (<.05) | 0.18 (<.05) | 0.17 (<.05) |
| Hb, mean (SEM) | 8.7 (0.1) | –0.15 (<.05) | –0.22 (<.01) | –0.20 (<.01) |
| MCV, mean (SEM) | 86.1 (1.0) | 0.08 (.29) | 0.13 (.11) | 0.11 (.17) |
| Hydroxyurea use (%) | 132 (63) | 0.10 (.07) | 0.13 (<.01) | 0.17 (<.05) |
MCV, mean corpuscular volume; SEM, standard error of the mean.